Mary Kay Fenton, SVP and CFO at ACHILLION PHARMACEUTICALS INC (ACHN), sold 15,000 shares at $12.00 ($168K) on 2012-01-10, disclosed to the SEC on 2012-01-11.
Scheduled sale ($168k) by SVP and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.34 | 4,375 | $41K | 24.3% |
| 2 | $12.00 | 10,625 | $128K | 75.7% |
| Total | $11.22 avg | 15,000 | $168K | 100% |
| Filing → |
| ACHN | SELL | 2015-12-30 | $438K | — | Filing → |
| ACHN | SELL | 2015-01-23 | $210K | — | Filing → |
| ACHN | SELL | 2011-04-06 | $32K | — | Filing → |